September 22nd, 2023

Astellas Pharma Inc. and Seagen Inc. (Nasdaq: SGEN) have reported promising results from the Phase 3 EV-302 clinical trial (KEYNOTE-A39) for PADCEV (enfortumab vedotin-ejfv) combined with Merck & Co., Inc.'s (NYSE: MRK) KEYTRUDA (pembrolizumab) versu. Read more

September 22nd, 2023

The European Commission has re-imposed a fine of approximately €376.36 million on Intel Corporation (Nasdaq: INTC) for anticompetitive practices in the x86 central processing unit (CPU) market dating back to 2009. These practices involved condit. Read more

September 22nd, 2023

The UK's Competition and Markets Authority (CMA) has indicated that the sale of Activision Blizzard, Inc.'s (Nasdaq: ATVI) cloud gaming rights to Ubisoft Entertainment SA has substantially addressed previous concerns, potentially paving the way for t. Read more

September 22nd, 2023

VinFast Auto Ltd. (Nasdaq: VFS) reported Q2 2023 revenues of $334.1 million, marking a 131.2% increase from Q2 2022 and a substantial 303.3% surge from Q1 2023. The company's net quarterly loss was $526.7 million, showing an improvement by decreasing. Read more

September 21st, 2023

Scholastic Corporation (Nasdaq: SCHL), a publishing and education company, reported first-quarter fiscal 2024 loss of $(2.20) per share, falling short of the consensus estimate loss of $(1.20). Quarterly sales stood at $228.50 million, missing analys. Read more

September 21st, 2023

Shares of The Greenbrier Companies, Inc. (NYSE: GBX) surged over 5% following the company's announcement of receiving orders for 15,300 new railcars during its fiscal fourth quarter, which ended on August 31, 2023. These substantial orders came fr. Read more

September 20th, 2023

FedEx Corporation (NYSE: FDX), a renowned global courier delivery services company, reported first-quarter fiscal 2024 earnings of $4.55 per share, surpassing the consensus EPS estimate of $3.73. The company's quarterly revenues amounted to $21.70 bi. Read more

September 20th, 2023

General Mills, Inc. (NYSE: GIS), a notable food products manufacturer, reported first-quarter fiscal 2024 adjusted earnings of $1.09 per share, surpassing the consensus EPS estimate of $1.08. Additionally, its quarterly sales amounted to $4.90 billio. Read more

September 20th, 2023

Shares of ARS Pharmaceuticals, Inc. (Nasdaq: SPRY) plunged over 40% following the announcement that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for neffy (epinephrine na. Read more

September 19th, 2023

Shares of Nano Dimension Ltd. (Nasdaq: NNDM) surged over 5% in after-hours trading following the company's announcement of receiving Israeli court approval to extend its share repurchase plan. The plan, originally approved by the Israeli court in Aug. Read more